Description
Rifaximin is a rifampicin derivative with weaker absorption kinetics; it inhibits DNA-dependent RNA polymerase. Rifaximin is an ansamycin antibacterial compound that is clinically used to treat small intestinal bacterial overgrowth in subjects with inflammatory bowel syndrome (IBS).